Elisabet I. Nielsen

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

Jesse J. Swen, Cathelijne H. van der Wouden, Lisanne E. N. Manson et al. · The Lancet · 2023 · 514 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Peptide hormone exendin‐4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of parkinson's disease

Göran Bertilsson, Cesare Patrone, Olof Zachrisson et al. · Journal of Neuroscience Research · 2007 · 342 citations

Life Sciences, Neurobiology, Neuroscience +17

Pharmacokinetic/Pharmacodynamic (PK/PD) Indices of Antibiotics Predicted by a Semimechanistic PKPD Model: a Step toward Model-Based Dose Optimization

Elisabet I. Nielsen, Otto Cars, Lena E. Friberg · Antimicrobial Agents and Chemotherapy · 2011 · 249 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Semimechanistic Pharmacokinetic/Pharmacodynamic Model for Assessment of Activity of Antibacterial Agents from Time-Kill Curve Experiments

Elisabet I. Nielsen, Anders Viberg, Elisabeth Löwdin et al. · Antimicrobial Agents and Chemotherapy · 2006 · 170 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

The glucagon-like peptide 1 receptor agonist exendin-4 improves reference memory performance and decreases immobility in the forced swim test

Ruben Isacson, Elisabet I. Nielsen, Karin Dannaeus et al. · European Journal of Pharmacology · 2010 · 150 citations

Social Sciences, Neuroscience, Physiology +11